- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/088 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Patent holdings for IPC class C07D 295/088
Total number of patents in this class: 424
10-year publication summary
|
32
|
35
|
32
|
26
|
37
|
40
|
32
|
26
|
29
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 36 |
14 |
| Alkermes Pharma Ireland Limited | 274 |
12 |
| The University of British Columbia | 1475 |
10 |
| Dow Global Technologies LLC | 10220 |
9 |
| Novartis AG | 11071 |
8 |
| British Columbia Cancer Agency Branch | 194 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2809 |
7 |
| BASF SE | 20548 |
6 |
| Bioprojet | 45 |
6 |
| The Scripps Research Institute | 1340 |
6 |
| Gotion Inc. | 38 |
6 |
| Translate bio, Inc. | 407 |
6 |
| Allergan, Inc. | 2372 |
5 |
| Sumitomo Chemical Company, Limited | 8973 |
5 |
| Board of Regents, The University of Texas System | 5672 |
5 |
| The Trustees of Columbia University in the City of New York | 3543 |
5 |
| Emory University | 1600 |
5 |
| Wave Life Sciences Ltd. | 160 |
5 |
| Merck Patent GmbH | 5824 |
4 |
| Bayer Pharma AG | 1059 |
4 |
| Other owners | 288 |